Proceeding contribution from Lord Hain (Labour) in the House of Commons on Thursday, 9 December 2004. It occurred during Business statement on Leader of the House of Commons.
Leader of the House of Commons
Secondary information
- Type
- Proceeding contribution
- Reference
- 428 c1284
- Session
- 2004-05
- Chamber / Committee
- House of Commons chamber
- Subjects
- Prescription drugs Side effects Paroxetine Antidepressants Dental services Africa Hospitals Disease control Hygiene Foreign relations NHS MRSA Middle East
- Legislation
- Constitutional Reform Bill (HL) 2003/04 to 2004/05
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 03:34:17 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_972216/answer
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_972216/answer
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_972216/answer